Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Merck
Express Scripts
Mallinckrodt
Medtronic
Moodys

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Apnar Pharma Lp Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for APNAR PHARMA LP, and what generic and branded alternatives to APNAR PHARMA LP drugs are available?

APNAR PHARMA LP has five approved drugs.



Summary for Apnar Pharma Lp
US Patents:0
Tradenames:4
Ingredients:4
NDAs:5

Drugs and US Patents for Apnar Pharma Lp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apnar Pharma Lp BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET;ORAL 075584-002 Feb 7, 2000 AB RX No No   Start Trial   Start Trial
Apnar Pharma Lp TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 074823-002 Mar 30, 1998 AB RX No Yes   Start Trial   Start Trial
Apnar Pharma Lp FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 075049-001 Aug 2, 2001 AB1 RX No No   Start Trial   Start Trial
Apnar Pharma Lp PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 076397-003 Oct 23, 2006 AB RX No No   Start Trial   Start Trial
Apnar Pharma Lp PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 076397-001 Oct 23, 2006 AB RX No No   Start Trial   Start Trial
Apnar Pharma Lp PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 076397-002 Oct 23, 2006 AB RX No No   Start Trial   Start Trial
Apnar Pharma Lp TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 074823-001 Mar 30, 1998 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Harvard Business School
Medtronic
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.